Month: October 2022

Alcanza is changing the model for research access to underrepresented people to enhance inclusion in clinical trials. Middle market healthcare fund Martis Capital has invested in Alcanza Clinical Research in order to meet the pressing requirements of equitable healthcare. Established…

Zelpultide alfa has received Orphan Drug Designation from the European Medicines Agency and the US FDA. Airway Therapeutics has dosed the first subject in its Phase Ib clinical trial of zelpultide alfa (rhSP-D) in Spain for preventative usage in very preterm infants…

Satisfai and Virgo will merge expertise with Alimentiv to attain AI-driven precision imaging’s full potential in a GI trial space. Satisfai Health and Virgo Surgical Video Solutions have entered a strategic collaboration with Alimentiv to leverage artificial intelligence (AI)-powered technology to boost…

Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound ~ To Support More Accurate Diagnosis and Treatment of Pancreaticobiliary and Lung Diseases ~ TOKYO & HAMBURG, Oct 7, 2022 – (JCN Newswire) – Olympus Corporation (Olympus), a global…

AstraZeneca’s rare disease firm Alexion is set to expand its genomic medicine portfolio with the acquisition of gene editing specialist LogicBio Therapeutics, in a deal worth approximately $68 million. US-based LogicBio is a clinical-stage genetic medicine company focused on genome…

The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an initial investment of approximately $55 million for rapid development of VIR-2482, the Vir Biotechnology’s investigational prophylactic monoclonal antibody (mAb) for seasonal and pandemic influenza viruses. Its purpose…